Why millions are trying FDA-approved alternatives to Big Pharma's weight loss drugs

Novo Nordisk and Lilly can't keep up with demand for their weight loss drugs such as Ozempic, Wegovy and Mounjaro. But they object to specialty pharmacies making their own cheaper versions to fill the gap — providing as much as 30% of those drugs sold in the U.S.

Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas United States Wyoming US Virgin Islands Utah Vermont Virginia Washington D.C. Washington West Virginia Porters Sideling Pennsylvania Folsom Louisiana
July 20, 2024 at 06:00AM